Answer
Patients receiving immunosuppressive therapy may not achieve an adequate immune response to Infanrix-IPV+Hib.
Sources for this answer
- Infanrix-IPV+Hib, powder and suspension for suspension for injectionGlaxoSmithKline UK · emc · SmPC §4.5 Interaction with other medicinal products · Version 10Document updated
Sources checked